Document is current
Any future updates will be listed below
-
Authors
Aguadé-Gorgorió, Júlia https://orcid.org/0000-0001-5600-4279
Jami-Alahmadi, Yasaman
Calvanese, Vincenzo https://orcid.org/0000-0002-7937-1511
Kardouh, Maya
Fares, Iman
Johnson, Haley
Rezek, Valerie https://orcid.org/0000-0002-2336-7599
Ma, Feiyang https://orcid.org/0000-0002-6260-0787
Magnusson, Mattias
Wang, Yanling
Shin, Juliana E.
Nance, Karina J.
Goodridge, Helen S.
Liebscher, Simone
Schenke-Layland, Katja https://orcid.org/0000-0001-8066-5157
Crooks, Gay M. https://orcid.org/0000-0002-2488-8468
Wohlschlegel, James A.
Mikkola, Hanna K. A. https://orcid.org/0000-0002-3400-1496
- License Information
-
More Information
Article History
Received: 30 May 2023
Accepted: 26 April 2024
First Online: 5 June 2024
Competing interests
: The authors declare the following competing interests: H.K.A.M is a scientific advisory board member for Notch therapeutics and a consultant for MaroBio. H.K.A.M. and J.A.-G. have submitted a provisional patent application based on the work presented here (“Methods and compositions for haematopoietic stem cell enhancement”; PCT patent application submitted; institution: UCLA; inventors: H.K.A.M. and J.A.-G.), covering increasing expression and/or activity of MYCT1 and controlling endocytosis in cultured HSCs to improve transplantability and/or provide better in vitro models for pluripotent stem cell-derived haematopoiesis. All other authors declare no competing interests.
